The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter

Kuan Hsun Wu, Chi Tang Ho, Zhao Feng Chen, Li Ching Chen, Jacqueline Whang-Peng, Teng Nan Lin, Yuan Soon Ho

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Human triple-negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer. Glucose transporters (GLUTs) are required for glucose uptake in malignant cancer cells and are ideal targets for cancer therapy. To determine whether the inhibition of GLUTs could be used in TNBC cell therapy, the apple polyphenol phloretin (Ph) was used as a specific antagonist of GLUT2 protein function in human TNBC cells. Interestingly, we found that Ph (10-150 μM, for 24 h) inhibited cell growth and arrested the cell cycle in MDA-MB-231 cells in a p53 mutant-dependent manner, which was confirmed by pre-treatment of the cells with a p53-specific dominant-negative expression vector. We also found that Ph treatment (10-150 μM, for 24 h) significantly decreased the migratory activity of the MDA-MB-231 cells through the inhibition of paxillin/FAK, Src, and alpha smooth muscle actin (α-sMA) and through the activation of E-cadherin. Furthermore, the anti-tumorigenic effect of Ph (10, 50 mg/kg or DMSO twice a week for six weeks) was demonstrated in vivo using BALB/c nude mice bearing MDA-MB-231 tumor xenografts. A decrease in N-cadherin, vimentin and an increase in p53, p21 and E-cadherin were detected in the tumor tissues. In conclusion, inhibition of GLUT2 by the apple polyphenol Ph could potentially suppress TNBC tumor cell growth and metastasis.

Original languageEnglish
Pages (from-to)221-231
JournalJournal of Food and Drug Analysis
Volume26
Issue number1
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Glucose Transporter Type 2
Phloretin
glucose transporters
Malus
Polyphenols
cell movement
breast neoplasms
Cell Movement
cell proliferation
polyphenols
Triple Negative Breast Neoplasms
apples
Cell Proliferation
cadherins
Breast Neoplasms
Cadherins
neoplasms
cell growth
Facilitative Glucose Transport Proteins
therapeutics

Keywords

  • Apple polyphenol
  • Breast cancer
  • Glucose transporter 2
  • Phloretin
  • Triple-negative breast cancer

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

Cite this

@article{3047343ce364419eb47c271f8fc9a2f1,
title = "The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter",
abstract = "Human triple-negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer. Glucose transporters (GLUTs) are required for glucose uptake in malignant cancer cells and are ideal targets for cancer therapy. To determine whether the inhibition of GLUTs could be used in TNBC cell therapy, the apple polyphenol phloretin (Ph) was used as a specific antagonist of GLUT2 protein function in human TNBC cells. Interestingly, we found that Ph (10-150 μM, for 24 h) inhibited cell growth and arrested the cell cycle in MDA-MB-231 cells in a p53 mutant-dependent manner, which was confirmed by pre-treatment of the cells with a p53-specific dominant-negative expression vector. We also found that Ph treatment (10-150 μM, for 24 h) significantly decreased the migratory activity of the MDA-MB-231 cells through the inhibition of paxillin/FAK, Src, and alpha smooth muscle actin (α-sMA) and through the activation of E-cadherin. Furthermore, the anti-tumorigenic effect of Ph (10, 50 mg/kg or DMSO twice a week for six weeks) was demonstrated in vivo using BALB/c nude mice bearing MDA-MB-231 tumor xenografts. A decrease in N-cadherin, vimentin and an increase in p53, p21 and E-cadherin were detected in the tumor tissues. In conclusion, inhibition of GLUT2 by the apple polyphenol Ph could potentially suppress TNBC tumor cell growth and metastasis.",
keywords = "Apple polyphenol, Breast cancer, Glucose transporter 2, Phloretin, Triple-negative breast cancer",
author = "Wu, {Kuan Hsun} and Ho, {Chi Tang} and Chen, {Zhao Feng} and Chen, {Li Ching} and Jacqueline Whang-Peng and Lin, {Teng Nan} and Ho, {Yuan Soon}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jfda.2017.03.009",
language = "English",
volume = "26",
pages = "221--231",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter

AU - Wu, Kuan Hsun

AU - Ho, Chi Tang

AU - Chen, Zhao Feng

AU - Chen, Li Ching

AU - Whang-Peng, Jacqueline

AU - Lin, Teng Nan

AU - Ho, Yuan Soon

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Human triple-negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer. Glucose transporters (GLUTs) are required for glucose uptake in malignant cancer cells and are ideal targets for cancer therapy. To determine whether the inhibition of GLUTs could be used in TNBC cell therapy, the apple polyphenol phloretin (Ph) was used as a specific antagonist of GLUT2 protein function in human TNBC cells. Interestingly, we found that Ph (10-150 μM, for 24 h) inhibited cell growth and arrested the cell cycle in MDA-MB-231 cells in a p53 mutant-dependent manner, which was confirmed by pre-treatment of the cells with a p53-specific dominant-negative expression vector. We also found that Ph treatment (10-150 μM, for 24 h) significantly decreased the migratory activity of the MDA-MB-231 cells through the inhibition of paxillin/FAK, Src, and alpha smooth muscle actin (α-sMA) and through the activation of E-cadherin. Furthermore, the anti-tumorigenic effect of Ph (10, 50 mg/kg or DMSO twice a week for six weeks) was demonstrated in vivo using BALB/c nude mice bearing MDA-MB-231 tumor xenografts. A decrease in N-cadherin, vimentin and an increase in p53, p21 and E-cadherin were detected in the tumor tissues. In conclusion, inhibition of GLUT2 by the apple polyphenol Ph could potentially suppress TNBC tumor cell growth and metastasis.

AB - Human triple-negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer. Glucose transporters (GLUTs) are required for glucose uptake in malignant cancer cells and are ideal targets for cancer therapy. To determine whether the inhibition of GLUTs could be used in TNBC cell therapy, the apple polyphenol phloretin (Ph) was used as a specific antagonist of GLUT2 protein function in human TNBC cells. Interestingly, we found that Ph (10-150 μM, for 24 h) inhibited cell growth and arrested the cell cycle in MDA-MB-231 cells in a p53 mutant-dependent manner, which was confirmed by pre-treatment of the cells with a p53-specific dominant-negative expression vector. We also found that Ph treatment (10-150 μM, for 24 h) significantly decreased the migratory activity of the MDA-MB-231 cells through the inhibition of paxillin/FAK, Src, and alpha smooth muscle actin (α-sMA) and through the activation of E-cadherin. Furthermore, the anti-tumorigenic effect of Ph (10, 50 mg/kg or DMSO twice a week for six weeks) was demonstrated in vivo using BALB/c nude mice bearing MDA-MB-231 tumor xenografts. A decrease in N-cadherin, vimentin and an increase in p53, p21 and E-cadherin were detected in the tumor tissues. In conclusion, inhibition of GLUT2 by the apple polyphenol Ph could potentially suppress TNBC tumor cell growth and metastasis.

KW - Apple polyphenol

KW - Breast cancer

KW - Glucose transporter 2

KW - Phloretin

KW - Triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=85018406351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018406351&partnerID=8YFLogxK

U2 - 10.1016/j.jfda.2017.03.009

DO - 10.1016/j.jfda.2017.03.009

M3 - Article

C2 - 29389559

AN - SCOPUS:85018406351

VL - 26

SP - 221

EP - 231

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 1

ER -